ASAP announces new teams joining the Collaborative Research Network! Learn More
Aligning Science Across Parkinson's Logo Text

Consensus Guidance for Genetic Counseling in GBA1 Variants: A Focus on Parkinson’s Disease

Output Details

Published September 10, 2024

Glucocerebrosidase (*GBA1*) variants constitute numerically the most common known genetic risk factor for Parkinson's disease (PD) and are distributed worldwide. Access to *GBA1* genotyping varies across the world and even regionally within countries. Guidelines for *GBA1* variant counseling are evolving. We review the current knowledge of the link between *GBA1* and PD, and discuss the practicalities of *GBA1* testing. Lastly, we provide a consensus for an approach to counseling people with *GBA1* variants, notably the communication of PD risk. © 2024 The Author(s). *Movement Disorders* published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Identifier (DOI)
10.1002/mds.30006
Tags
  • Review

Meet the Authors

  • User avatar fallback logo

    Sophia R.L. Vieira

    External Collaborator

  • User avatar fallback logo

    Roxana Mezabrovschi

    External Collaborator

  • User avatar fallback logo

    Marco Toffoli

    External Collaborator

  • User avatar fallback logo

    Sara Lucas Del Pozo

    External Collaborator

  • User avatar fallback logo

    Elisa Menozzi

    External Collaborator

  • User avatar fallback logo

    Stephen Mullin

    External Collaborator

  • User avatar fallback logo

    Selen Yalkic

    External Collaborator

  • User avatar fallback logo

    Naomi Limbachiya

    External Collaborator

  • Sofia Koletsi, MSc

    Project Manager: Team Schapira

    University College London

  • User avatar fallback logo

    Nadine Loefflad

    External Collaborator

  • User avatar fallback logo

    Grisel J. Lopez

    External Collaborator

  • User avatar fallback logo

    Ziv Gan-Or

    External Collaborator

  • User avatar fallback logo

    Roy N. Alcalay

    External Collaborator

  • Ellen Sidransky, MD

    Co-PI (Core Leadership): Team Vangheluwe

    National Human Genome Research Institute

  • Anthony Schapira, PhD

    Lead PI (Core Leadership): Team Schapira

    University College London

Aligning Science Across Parkinson's
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.